Abstract:Macrocyclic peptides are predominantly peptide structures bearing one or more rings and spanning multiple amino acid residues. Macrocyclization has become a common approach for improving the pharmacological properties and bioactivity of peptides. A variety of ribosomal-derived and non-ribosomal synthesized cyclization approaches have been established. The biosynthesis of backbone macrocyclic peptides using seven new emerging methodologies will be discussed with regard to the features and strengths of each platform rather than medicinal chemistry tools. The mRNA display variant, known as the random nonstandard peptide integrated discovery (RaPID) platform, utilizes flexible in vitro translation (FIT) to access macrocyclic peptides containing nonproteinogenic amino acids (NAAs). As a new discovery approach, the ribosomally synthesized and post-translationally modified peptides (RiPPs) method involves the combination of ribosomal synthesis and the phage screening platform together with macrocyclization chemistries to generate libraries of macrocyclic peptides. Meanwhile, the split-intein circular ligation of peptides and proteins (SICLOPPS) approach relies on the in vivo production of macrocyclic peptides. In vitro and in vivo peptide library screening is discussed as an advanced strategy for cyclic peptide selection. Specifically, biosynthetic bicyclic peptides are highlighted as versatile and attractive modalities. Bicyclic peptides represent another type of promising therapeutics that allow for building blocks with a heterotrimeric conjugate to address intractable challenges and enable multimer complexes via linkers. Additionally, we discuss the cell-free chemoenzymatic synthesis of macrocyclic peptides with a non-ribosomal catalase known as the non-ribosomal synthetase (NRPS) and chemo-enzymatic approach, with recombinant thioesterase (TE) domains. Novel insights into the use of peptide library tools, activity-based two-hybrid screening, structure diversification, inclusion of NAAs, combinatorial libraries, expanding the toolbox for macrocyclic peptides, bicyclic peptides, chemoenzymatic strategies, and future perspectives are presented. This review highlights the broad spectrum of strategy classes, novel platforms, structure diversity, chemical space, and functionalities of macrocyclic peptides enabled by emerging biosynthetic platforms to achieve bioactivity and for therapeutic purposes.

A platform approach to mechanically caged molecules

A Platform Approach to Cleavable Macrocycles for the Controlled Disassembly of Mechanically Caged Molecules

A Macrocycle-Mediated Protein Cage

Biosynthetic Strategies for Macrocyclic Peptides

Generation of Multicomponent Molecular Cages using Simultaneous Dynamic Covalent Reactions.

An Amphiphilic Cell‐Penetrating Macrocycle for Efficient Cytosolic Delivery of Proteins, DNA and CRISPR Cas9

Active Molecular Gripper as a Macrocycle Synthesizer

A quantitative active template click reaction (AT-CuAAC) for the synthesis of mechanically interlocked nanohoops

Main Group Supramolecular Chemistry Led to Surprising New Directions in the Self-Assembly of Organic Macrocycles, Cages, and Cyclophanes

Chemically revertible molecular clasps: Hydroxamic acid-mediated peptide macrocyclization and linearization

Peptide/protein-based Macrocycles: from Biological Synthesis to Biomedical Applications

A Dynamic Tetracationic Macrocycle Exhibiting Photoswitchable Molecular Encapsulation

Advancing multicomponent strategies to macrobicyclic peptides

Engineering organic macrocycles and cages: versatile bonding approaches.

Recent Advances in Peptide Macrocyclization Strategies.

Expansive discovery of chemically diverse structured macrocyclic oligoamides

A high‐yielding active template click reaction (AT‐CuAAC) for the synthesis of mechanically interlocked nanohoops

Transition-Metal-Catalyzed C–C Bond Macrocyclization via Intramolecular C–H Bond Activation

Identification of "Structural Pin" Interactions and Their Significance for the Conformational Control of Macrocyclic Scaffolds

Macrocyclic Peptide Construction Through C-H Activation Strategy.

A Redox‐active Cyclometalated Platinum Ring Enables Synthetic Post‐processing of a [2]Rotaxane